Ranibizumab, identified by its chemical formula 347396-82-1, represents a significant innovation in ophthalmology, acting as a highly selective blocker of Vascular Endothelial Growth Factor A (VEGF-A). This medication https://www.targetmol.com/compound/ranibizumab